See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!
Holiday Notification: Cayman Chemical will be closed Monday, May 28, 2012, in observance of the Memorial Day holiday.
More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, May 29, 2012. Thank you for your patience and understanding.
Chemical Class · Lipid Mediators
· See all 100+ product categories
| Item Number | Product | Sizes & Pricing | CAS | Purity | Image | Exclusive | Introduction Date | Mojo | Plain Text Name | Synonyms | Keywords | Interest |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10009879 |
1,2- |
3436-44-0 | ≥98% |
|
2007-08-02 | 3.969530386740 | 1-2-didecanoyl-pc | 1,2-Didecanoyl Phosphatidylcholine; Didecanoyl Lecithin | lecithin phosphatidylcholines phospholipids mammalian cells membranes lipids growth hormones GH intranasally | 3.969530386740 | ||
| 10141 |
15- |
- | >98% |
|
2005-10-11 | 20.766694495600 | 15-deoxy-12-14-prostaglandin-j2-biotin | 15-deoxy-Δ12,14-PGJ2-biotin | affinity probes binding proteins cyclopentenones PGs prostaglandins peroxisomes proliferator-activated receptors PPARs anitmitotic antiproliferative genes expressions non-classical non-GPCR gene protein-coupled detected detection interactions biotins ligands complexes nuclear nucleic acids elucidations mechanisms biotinylated PGJ2 biotinamides | 20.766694495600 | ||
| 10006692 |
(+)- |
54276-22-1 | ≥98% |
|
2005-05-18 | 6.888674033149 | -15-epi-cloprostenol | (+)-15(S)-Cloprostenol; D-Cloprostenol | prostaglandins F2.alpha. PGF2a analogs cloprostenols FP agonists 15(S) 15-epi C-15 epimers receptors 15b 15.beta.-hydroxy enantiomers ligands isomers | 6.888674033149 | ||
| 9000341 |
1- |
- | ≥98% |
|
2009-05-01 | 8.557642725598 | 1-nbd-decanoyl-2-decanoyl-sn-glycerol | fluorescent DAG PKC second messengers diacylglycerols signaling activator ERK MAPK RasGRP binding | 8.557642725598 | |||
| 10009651 |
2- |
112014-15-0 | ≥97% |
|
2007-02-22 | 8.737748618784 | 2-thio-acetyl-mage | KIAA1363 cancers colorimetric substrates activity inhibition inhibits inhibitory enzymatic activity | 8.737748618784 | |||
| 16300 |
5- |
180469-63-0 | ≥95% |
|
✓ | 2006-02-06 | 11.565193370165 | 5-ipf2-vi | iPF2α-I | marker oxidative injury 8-isoprostanes prostaglandins PGs free-radical lipids peroxidations ipf2a arachidonic acids polyunsaturated fatty stereo- regioisomeric oxidative stress Type VI internal lactones facilitates extraction purification pgf2a | 11.565193370165 | |
| 10006654 |
5- |
- | ≥99% deuterated forms (d1-d11) |
|
2005-03-17 | 122.834497237569 | 5-ipf2-vi-d11 | isoprostanes peroxidation oxidative injury deuterateds deuteriums isotopes 8,12-isoprostanes iPF2alpha-VI-d11 prostaglandins iPF2a-VI-d11 urine peroxidative damage enantiomers stress | 122.834497237569 | |||
| 10006878 |
8,12- |
- | ≥99% deuterated forms (d1-d11) |
|
✓ | 2005-09-01 | 7.929696132596 | 8-12-iso-ipf2-vi-d11 | 8,12-epi-iPF2α-VI-d11 | GC/MS deuterium isotopes internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry analogs internal standards isoprostanes prostaglandins free-radical lipid peroxidation stero- regioisomers arachidonic acids 8-isoprostane 8-epi-PGF2.alpha. iPF2.alpha.-III oxidative stress Type VI class internal lactones facilitates extraction and purification neurochemistry neuroscience | 7.929696132596 | |
| 10007417 |
9- |
106689-24-1 | ≥98% |
|
2005-07-20 | 1.194226519337 | 9-thiastearic-acid | heteroatom-substituted fatty acids modulates extensions desaturating distribution phospholipids pools radiolabeled stearate oleate rat hepatocytes hepatoma cellshypolipidemic effects anti-obesity therapeutics | 1.194226519337 | |||
| 10006607 | Arachidonic Acid (sodium salt) | 6610-25-9 | >98% |
|
2005-03-08 | 24.705895027624 | arachidonic-acid-sodium-salt | Sodium Arachidonate | PUFAs AA diets EFA w-6 omega-6 .omega.-6 polyunsaturated fatty acids deficiency biosynthesis eicosanoids signalling inflammations | 24.705895027624 | ||
| 10009052 |
AS- |
900515-16-4 | ≥95% |
|
2007-01-30 | 25.573676284018 | as-252424 | phosphoinositides 3-kinases PI-3 PI3-K Phosphatidylinositol inhibitors PI3K .gamma. inhibition inhibitory PtdIns AS252424 | 25.573676284018 | |||
| 70770 |
BAY- |
154978-38-8 | >95% |
|
2005-03-30 | 42.649613259668 | bay-u9773 | asthma leukotrienes CysLTs allergy antagonists cysteinyls receptors 7-transmembranes pranlukasts montelukasts CysLT2 CysLT1 CysLT-1 CysLT-2 | 42.649613259668 | |||
| 10155 | BM 567 | 284464-77-3 | >98% |
|
2005-03-31 | 43.370676795580 | bm-567 | platelets thromboxanes TXA2 atherosclerosis synthases inhibits inhibition inhibitors antagonists BM567 BM-567 thrombogenic vasocontrictors TP receptors eicosanoids strokes myocardial infarctions GPCR vascular smooth muscles protein-coupled license:liege | 43.370676795580 | |||
| 10004259 | CAY10429 | 22972-55-0 | >98% |
|
2005-02-09 | 32.021406328478 | cay10429 | Abnormal Cannabidiol; Abn-CBD | endocannabinoids cannabidiols abnormal abn-cbd non-CB1 non-CB2 receptors agonists BV-2 microglials hypotensives GPCR neurochemistry neuroscience | 32.021406328478 | ||
| 10005067 | CAY10434 | - | >98% |
|
2005-01-19 | 13.084198895027 | cay10434 | CYP20-HETE CYP450 cytochromes renal kidney metabolites arachidonic acid enzymes CYP4A11 inhibits inhibitors inhibition imidazoles | 13.084198895027 | |||
| 10009167 | CAY10509 | 1245699-47-1 | ≥98% |
|
2006-10-25 | 87.593895027624 | cay10509 | FP PGF2.alpha. glaucoma compound A receptors agonists intraocular pressure glaucoma IOP ophthalmology | 87.593895027624 | |||
| 10011286 | Chenodeoxycholic Acid | 474-25-9 | ≥95% |
|
2009-02-25 | 30.085602209944 | chenodeoxycholic-acid | Ulmenide; Kebilis; Anthropodeoxycholic Acid; Hekbilin; Fluibil; CDCA | FXR biles acids cholesterol oxidative stress glutathione cancers atherosclerosis diabetes hyperlipidemia CDA | 30.085602209944 | ||
| 10018 | DDMS | 206052-03-1 | >98% |
|
2005-02-22 | 9.518784530387 | ddms | Dibromo-dodecenyl-methylsulfimide | 20-HETEs inhibits inhibitors inhibition synthesis CYP450-4A2 renal hypotension vascular homeostasis circulation kidneys vasodilation vasodilators NONOates CYP4A2 donors cytochrome | 9.518784530387 | ||
| 10007907 |
D- |
123-78-4 | >98% |
|
2007-01-17 | 18.175862492326 | d-erythro-sphingosine-c-18 | (-)-Sphingosine | Sphingosines S1P sphingosine-1-phosphates kinases SPHK1 SPHK2 Proliferation cancers inhibits inhibitors inhibition ceramides DAG diacylglycerols cells phophorylation morphogenesis SK1 sphingolipids SK2 anti-proliferative | 18.175862492326 | ||
| 10006580 |
Dihomo- |
21061-10-9 | >98% |
|
2005-03-04 | 15.406009821976 | dihomo-linolenic-acid-methyl-ester | Methyl DGLA | fatty acids PUFAs primrose .omega.-6 omega-6 polyunsaturated dihomo-g-linolenic dihomo-.gamma.-linolenic dihomo-gamma-linolenic w-6 | 15.406009821976 | ||
| 10006305 |
D- |
35922-06-6 | ≥98% |
|
✓ | 2005-02-23 | 16.744126481115 | d-nmappd | CAY10466; (1R,2R)-B13 | ceramides inhibitors cancers cells inhibits inhibition ceramidase apoptosis colorectal keratinocytes melanoma lines viability inducers induces | 16.744126481115 | |
| 10009880 | GW 590735 Exclusive | 622402-22-6 | ≥98% |
|
✓ | 2007-06-18 | 9.053149171270 | gw-590735 | PPAR PPAR.alpha. PPAR.BETA. PPAR.gamma. PPAR.delta. receptor transcription factors lipidtriglyceride TG lipoprotein VLDL ApoCIII ApoA1 HDL atherosclerosis endocrinology | 9.053149171270 | ||
| 10006695 | HEPC | 60793-01-3 | ≥95% |
|
2005-03-29 | 3.870508287293 | hepc | 2-Hexadecanoylthio-1-Ethylphosphorylcholine | PLA2 phospholipases substrates thiesters PL Ellman's reagent colorimetric analogs glyceerophospholipids activity phosphatidylcholine Type II porcine pancreatic bee venoms snake | 3.870508287293 | ||
| 75780 | HET0016 | 339068-25-6 | ≥98% |
|
2005-01-31 | 54.900193370165 | het0016 | N-hydroxy-N'-(4-n-butyl-2-methylphenyl)Formamidine | 20-HETEs kidney cytochromes CYP450 hypertension cerebral vascular diseases metabolites arachidonic acids liver CYP4F inhibitors inhibition inhibits CYP4A CYP2C9 CYP2D6 CYP3A4 cyclooxygenases COX PGHS prostaglandins synthases EETs epoxyeicosatrienoic | 54.900193370165 | ||
| 10008661 | JP104 Exclusive | - | ≥98% |
|
✓ | 2006-09-05 | 7.391034655951 | jp104 | click chemistry probes FAAH fatty acids amides hydrolases inhibits inhibitors inhibition URB598 acyl anandamide AEA esters unsaturated carbamates neurochemistry | 7.391034655951 | ||
| 10008660 | JP83 | 887264-44-0 | ≥98% |
|
2006-08-30 | 6.974116022099 | jp83 | FAAH fatty acids amides hydrolases inhibits inhibitors inhibition URB597 acyl anandamide AEA esters unsaturated carbamates arachidonoyl ethanolamides neurochemistry | 6.974116022099 | |||
| 10009458 |
JTE- |
383150-41-2 | ≥98% |
|
2007-01-18 | 70.191724984653 | jte-013 | reverses inhibition inhibits coronary artery smooth muscles lipids cells proliferation cytoskeletal morphogenesis GPCRs protein-coupled receptors antagonists S1P2 humans rats EDG5 sphingosines sphingosine-1-phosphates sphingosine1 inhibitors JTE013 FDG-5 cancers | 70.191724984653 | |||
| 10006626 | Lauric Acid | 143-07-7 | >98% |
|
2005-04-20 | 15.110616729759 | lauric-acid | saturated fatty acids synthesized synthesis plants animals acetyl coenzymes CoA energy storage 12-carbons coconut nut oils COX-2 cyclooxygenase-2 cyclooxygenases expressions C:8-18 | 15.110616729759 | |||
| 10005610 |
N- |
63155-80-6 | >98% |
|
2005-02-09 | 6.968275453828 | n-stearoyl-taurine | endocannabinoids fatty amides oleamides amino-acyl bovine brain rat lipidomics neurochemistry neuroscience TRPV1 TRPV4 FAAH cannabinoids cbs synthetic | 6.968275453828 | |||
| 10006627 | Palmitic Acid | 57-10-3 | >98% |
|
2005-04-20 | 12.955420414705 | palmitic-acid | saturated fatty acids synthesized synthesis plants animals acetyl coenzymes CoA energy storage 16-carbon dietary fats plasma lipoproteins expression COX-2 cyclooxygenase-2 cyclooxygenases proteins acylation lipids anchoring signaling signalling molecules | 12.955420414705 | |||
| 10006451 | Pentacosanoic Acid methyl ester | 55373-89-2 | ≥98% |
|
2005-10-03 | 56.582243093922 | pentacosanoic-acid-methyl-ester | Methyl Pentacosanoate | fatty acids long chain saturateds esters components plant lipids methyl 25-carbon pentacosanoic standard analysis saturates | 56.582243093922 | ||
| 10006697 |
Prostaglandin D2- |
- | >95% |
|
2005-08-03 | 34.030055248618 | prostaglandin-d2-biotin | PGD2-biotin | PgD2 biotinylated prostaglandins biotins biotinamide affinity probes ligand receptors PGs | 34.030055248618 | ||
| 512031 | Prostaglandin D2 EIA Kit | - |
|
2010-07-19 | 203.609714548802 | prostaglandin-d2-eia-kit | PGD2 ELISA Kit | PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions | 203.609714548802 | |||
| 512041 | Prostaglandin D2 Express EIA Kit | - |
|
2010-07-19 | 105.423217169570 | prostaglandin-d2-express-eia-kit | PGD2 Express ELISA Kit | PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions | 105.423217169570 | |||
| 10006987 |
Prostaglandin E2- |
- | >95% |
|
2005-07-26 | 35.972891344382 | prostaglandin-e2-biotin | PGE2-biotin | prostaglandins biotinimides eicosanoids COX-1 COX-2 cyclooxygenases reproductive tissues contracts bronchial smooth muscles regulates fertility implantation FP receptors GPCR affinity probes detected detection interaction biotins ligands transmembrane receptors nucleic acids proteins binding partners tool elucidations mechanisms biotins biotinylated | 35.972891344382 | ||
| 10006988 |
Prostaglandin F2α- |
- | >96% |
|
2005-07-26 | 12.379591160220 | prostaglandin-f2-biotin | PGF2α-biotin | prostaglandins biotinimides eicosanoids COX-1 COX-2 cyclooxygenases reproductive tissues contracts bronchial smooth muscles regulates fertility implantation FP receptors GPCR affinity probes detected detection interaction biotins ligands transmembrane receptors nucleic acids proteins binding partners tool elucidations mechanisms biotins biotinylated | 12.379591160220 | ||
| 10006800 |
(R)- |
478288-90-3 | ≥98% |
|
✓ | 2005-05-31 | 12.755395948434 | -r-bromoenol-lactone | (R)-BEL | selective iPLA2 inhibitors phospholipases PLAs BEL iPLA2b iPLA2.beta. iPLA2g iPLA2.gamma. lipids hydrolases cells signaling digestion membrane remodeling venom calcium independent releases AA arachidonic acids physiologic stimuli irreversible chiral mechanism-based human recombinants | 12.755395948434 | |
| 10534 |
(R)- |
- | ≥99% deuterated forms (d1-d7) |
|
✓ | 2010-06-17 | 7.613259668508 | -r-bromoenol-lactone-d7 | (R)-BEL-d7 | selective iPLA2 inhibitors phospholipases PLAs BEL iPLA2b iPLA2.beta. iPLA2g iPLA2.gamma. lipids hydrolases cells signaling digestion membrane remodeling venom calcium independent releases AA arachidonic acids physiologic stimuli irreversible chiral mechanism-based human recombinants deuterium deuterateds GC/MS LC/MS LC-MS GC-MS mass spectrometry MS signalling standards | 7.613259668508 | |
| 10012554 | Resolvin D1 Exclusive | 872993-05-0 | ≥95% |
|
✓ | 2008-06-06 | 256.332392917195 | resolvin-d1 | RvD1; 17(S)-Resolvin D1 | EPA DHA inflammation antiinflammatory anti-inflammatory immune responses aspirin LOX peritonitis LOS neurochemistry resolvins 10007848 | 256.332392917195 | |
| 10007279 | Resolvin D2 Exclusive | 810668-37-2 | ≥95% |
|
✓ | 2010-06-25 | 140.031152498541 | resolvin-d2 | 7(S),16(R),17(S)-Resolvin D2 | EPA DHA inflammation anti-inflammatory antiinflammatory immune responses sepsis Docosahexaenoic Acid 4,7,10,13,16,19-(Z,Z,Z,Z,Z,E-Isomer) Docosahexaenoic Acid 4,7,10,13,16,19-(All-Z-Isomer) Docosahexaenoic Acid 4,7,10,13,16,19-Isomer Docosahexaenoic Acid 3,6,9,12,15,18-Isomer Docosahexaenoic Acid Dimer (All-Z Isomer) Docosahexaenoic Acid (All-Z Isomer) Acids Docosahexaenoic Docosahexaenoic Acids Acids Docosahexenoic Docosahexenoic Acids Docosahexaenoic Acid Docosahexaenoate 10007848 | 140.031152498541 | |
| 10006801 |
(S)- |
478288-94-7 | ≥98% |
|
2005-05-31 | 12.718747697974 | -s-bromoenol-lactone | (S)-BEL | selective iPLA2 inhibitors phospholipases PLAs BEL iPLA2b iPLA2.beta. iPLA2g iPLA2.gamma. lipids hydrolases cells signaling digestion membrane remodeling venom calcium independent releases AA arachidonic acids physiologic stimuli irreversible chiral mechanism-based vasopression-induced rat aortic smooth muscle A10 | 12.718747697974 | ||
| 10535 |
(S)- |
- | ≥99% deuterated forms (d1-d7) |
|
✓ | 2010-06-17 | 8.306298342541 | -s-bromoenol-lactone-d7 | (S)-BEL-d7 | selective iPLA2 inhibitors phospholipases PLAs BEL iPLA2b iPLA2.beta. iPLA2g iPLA2.gamma. lipids hydrolases cells signaling digestion membrane remodeling venom calcium independent releases AA arachidonic acids physiologic stimuli irreversible chiral mechanism-based vasopression-induced rat aortic smooth muscle A10 deuterium deuterateds GC/MS GC-MS LC/MS LC-MS mass spectrometry MS signalling standards | 8.306298342541 | |
| 10006610 | Thromboxane B1 | 64626-32-0 | >98% |
|
2005-09-13 | 25.741850828729 | thromboxane-b1 | thromboxanes TXB1 DGLA dihomo-.gamma.-linolenic acids dihomo-g-linolenic metabolites cyclooxygenases COX-1 TXA synthases 20-carbon fatty metabolized prostaglandins COX-2 metabolism human platelets 1-series 12-lipoxygenases 12-LO specific biomarkers ethanol abuses | 25.741850828729 | |||
| 10006731 | VDM11 | 313998-81-1 | >98% |
|
2005-07-13 | 9.313609576427 | vdm11 | analogs arachidonoyls ethanolamides AEA anadamides potentiates activity inhibits inhibition reuptake neurons FAAH fatty amides acyls hydrolases transport CB1 CB2 cannabinoids VR1 vanilloid receptors AM404 glutamergic synaptic transmission hippocampal mechanisms sodium channels neurochemistry neuroscience | 9.313609576427 | |||
| 10006579 |
γ- |
16326-32-2 | >98% |
|
2005-03-04 | 4.030134175216 | -linolenic-acid-methyl-ester | γ-Linolenic Acid methyl ester; Methyl GLA; Methyl γ-Linolenate | fatty acids PUFAs gamma-linolenic g-linolenic .omega.-6 omega-6 .gamma.-linolenic polyunsaturated defiency diets bronchioconstriction | 4.030134175216 | ||
| 10009348 |
ω- |
123940-93-2 | >98% |
|
2007-01-05 | 25.942191528545 | -3-arachidonic-acid-ethyl-ester | .omega.-3 w-3 omega-3 fatty acids fish oils polyunsaturateds PUFAs diet omega3 w3 GC exogenous 8Z,11Z,14Z,17Z-eicosatetraenoic 8,11,14,17-eicosatetraenoic arachidonoates essential lipid-soluble esters FAME heart diseases thrombosis hypertension inflammatory autoimmune arachidonoyl-CoA synthetases calf brains lipophilic | 25.942191528545 | |||
| 10006454 |
ω- |
132712-70-0 | >98% |
|
2005-06-29 | 21.560128913443 | -3-arachidonic-acid-methyl-ester | w-3 omega-3 fatty acids fish oils polyunsaturateds PUFAs diet omega3 w3 GC exogenous 8Z,11Z,14Z,17Z-eicosatetraenoic 8,11,14,17-eicosatetraenoic arachidonoates essential lipid-soluble esters FAME | 21.560128913443 |
Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA
Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640
Copyright 2012 Cayman Chemical Company
Quick Search